Labelling Drugs for the Elderly

Frais, J. A.
March 1971
British Medical Journal;3/27/1971, Vol. 1 Issue 5751, p729
Academic Journal
No abstract available.


Related Articles

  • FDA adding `geriatric use' in drug labeling. James G., Dickinson // Medical Marketing & Media;Oct97, Vol. 32 Issue 10, p32 

    Reports on the US Food and Drug Association's requirement on drug and biologic manufacturers to include pertinent information to the appropriate use of drugs in the elderly. Creation of a geriatric use subsection in drug labeling.

  • OF SPECIAL INTEREST.  // American Journal of Health-System Pharmacy;12/1/2005, Vol. 62 Issue 23, p2431 

    Reports developments on medicines. Approval of labeling of duloxetine drug by the Food and Drug Administration; Significance of atorvastatin in patients with hyperlipidemia; Impact of the nonsteroidal anti-inflammatory drugs on hospitalized elderly patients.

  • Drug effects in elderly.  // FDA Consumer;Mar1991, Vol. 25 Issue 2, p4 

    Announces that information on the effects of prescription drugs in persons over 65 would be included in the physician labeling for drugs under a new requirement proposed by the Food and Drug Administration. Labeling would include all available information on the effects of the drug in the...

  • Seniors and switches. Snyder, Karyn // Drug Topics;12/9/96, Vol. 140 Issue 23, p74 

    Points out the risks faced by elderly patients from the drug industry's switch from prescription to over the counter (OTC) drugs. Percentage of the elderly who use non-prescription drugs; Rampant practice of self-medication among the very old and the very poor; Petition for labeling changes in...

  • Can drug compliance in the elderly be improved? Wandless, I.; Davie, J.W. // British Medical Journal;2/5/1977, Vol. 1 Issue 6057, p359 

    Examines the improvement of drug compliance in the elderly. Instruction schemes for self-medication in the aged; Provision of planned instructions and labelling the medication; Impact of verbal instructions on compliance of patients.

  • Medication use and the elderly: Current status and opportunities. Avorn, Jerry // Health Affairs;Spring1995, Vol. 14 Issue 1, p276 

    Presents recommendations designed to define the current issues relating to medication use by the elderly in the United States. Guide to future activities of health care policymakers; Drug testing, development and labeling; Improvement of prescribing and utilization; Measurement of the effect of...

  • Off-Label Prescribing in Older People: The Need for Increased Awareness and Caution. Stephenson, Anne; Anderson, Geoffrey M.; Rochon, Paula // Drugs & Aging;2012, Vol. 29 Issue 6, p435 

    The authors discuss the need for raising awareness and increased caution in off-label prescribing of drugs in older people. They explore the study by Jackson and colleagues which outlines strategies for assisting practitioners in considering off-label medication in elderly. They emphasize the...

  • Label Literacy.  // Current Health 2;Nov2007, Vol. 34 Issue 3, p6 

    The article explains the parts of a drug label.

  • Use and labels highlighted in supplement news. Edmonds, Bryce // Natural Foods Merchandiser;Feb2006, Vol. 27 Issue 2, p6 

    The article reports on several research from the U.S. regarding the usage of patterns of alternative remedies and the ability of labels to educate consumers. A study conducted by researchers at Wake Forest University School of Medicine has showed that elderly black and Native Americans use more...

  • Drug treatment in elderly patients: GP audit. Martys, Cedrick R. // British Medical Journal (Clinical Research Edition);12/4/1982, Vol. 285 Issue 6355, p1621 

    Examines the drug treatment of elderly patients. Growth in the population of elderly people; Adverse effects of drugs on patients; Identification of problems associated with drug treatment of elderly patients.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics